Myriad Genetics MYGN Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$34.1M-332% | -$7.9M+71.2% | -$27.4M+91.7% | -$330.5M-330,400% | -$100K+99.8% | ||
| $12.5M-0.8% | $12.6M0.0% | $12.6M-10.6% | $14.1M-2.1% | $14.4M-2.7% | ||
| $6.5M+132% | $2.8M-77.0% | $12.2M+14.0% | $10.7M+12.6% | $9.5M-12.8% | ||
| $5.4M+100% | $2.7M— | $0-100% | $316.7M— | $0-100% | ||
| $8.7M+435% | -$2.6M+86.3% | -$19M-217% | $16.2M+2,125% | -$800K— | ||
| -$2.7M— | —— | $2.9M+867% | $300K-66.7% | $900K-30.8% | ||
| $5.4M+229% | -$4.2M-425% | -$800K-122% | $3.6M— | $0— | ||
| -$7.4M-10.4% | -$6.7M— | —— | -$16.8M-35.5% | -$12.4M+54.9% | ||
| $500K+171% | -$700K-16.7% | -$600K-200% | -$200K+60.0% | -$500K-150% | ||
| $1.2M-33.3% | $1.8M+38.5% | $1.3M— | $0-100% | $500K+66.7% | ||
| $1M-9.1% | $1.1M+10.0% | $1M-64.3% | $2.8M0.0% | $2.8M0.0% | ||
| -$15.7M-248% | $10.6M-49.8% | $21.1M+255% | -$13.6M+16.6% | -$16.3M— | ||
| $1.1M-15.4% | $1.3M-61.8% | $3.4M-17.1% | $4.1M+36.7% | $3M+30.4% | ||
| -$6.5M-8.3% | -$6M+3.2% | -$6.2M+10.1% | -$6.9M+16.9% | -$8.3M-40.7% | ||
| $0— | —— | —— | —— | $40M+100% | ||
| $0— | —— | $60M— | —— | $20.5M+5.1% | ||
| $100K— | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| $2.9M+142% | $1.2M+300% | $300K— | $0-100% | $5.8M+383% | ||
| -$3M— | —— | $56.2M+2,062% | $2.6M-80.9% | $13.6M— | ||
| -$100K-200% | $100K— | $0-100% | $600K+500% | $100K+114% | ||
| -$25.3M— | $0-100% | $71.1M+511% | -$17.3M-58.7% | -$10.9M— | ||
| $5.4M+100% | $2.7M— | $0-100% | $316.7M— | $0-100% | ||
| $9.7M+394% | -$3.3M-197% | $3.4M+236% | -$2.5M-214% | $2.2M— | ||
| -$10M-456% | -$1.8M-260% | -$500K— | $0+100% | -$2.1M-250% | ||
| $0-100% | $64M— | $0+100% | -$200K+99.4% | -$31.3M-746% | ||
| $1M-9.1% | $1.1M+10.0% | $1M-64.3% | $2.8M0.0% | $2.8M0.0% | ||
| $1.1M-15.4% | $1.3M-61.8% | $3.4M-17.1% | $4.1M+36.7% | $3M+30.4% | ||
| $5.4M+14.9% | $4.7M+67.9% | $2.8M0.0% | $2.8M-47.2% | $5.3M+47.2% | ||
| $100K— | —— | $100K0.0% | $100K0.0% | $100K0.0% | ||
| —— | $1.88M0.0% | $1.88M0.0% | $1.88M0.0% | $1.88M— | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | -$50K0.0% | -$50K0.0% | -$50K0.0% | -$50K+50.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Myriad Genetics generate?
- Myriad Genetics (MYGN) generated $2.4M in operating cash flow over the trailing twelve months.
- Where does Myriad Genetics's cash flow data come from?
- Every line is extracted from Myriad Genetics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
